| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. (ARQT) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ARQT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 740.5K | $19.85M | - | |
| Other | 150.2K | $4.03M | - | |
| Other | 127.6K | $3.42M | - | |
| Other | 120.2K | $3.22M | - | |
| CFO | 86.0K | $2.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2021 | Chaudhuri Bhaskar78 | Director | Sell | 10,000 | $27.50 | $275,000.00 | -1.2% | -23.2% | -26.0% | |
| May 7, 2021 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 750 | $35.00 | $26,250.00 | -0.1% | -36.0% | -43.2% | |
| May 5, 2021 | Watanabe Todd Franklin65 | President And CEO | Sale+OE | 1,750 | $34.00 | $59,500.00 | -0.3% | -32.0% | -37.4% | |
| May 3, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,200 | $34.79 | $76,547.39 | -0.5% | -33.0% | -38.1% | |
| Apr 30, 2021 | Watanabe Todd Franklin65 | President And CEO | Sell | 1,500 | $35.00 | $52,500.00 | -0.3% | -29.4% | -39.7% | |
| Apr 20, 2021 | Chaudhuri Bhaskar78 | Director | Sell | 10,000 | $28.06 | $280,568.20 | -0.6% | -10.2% | -27.6% | |
| Apr 5, 2021 | Watanabe Todd Franklin65 | President And CEO | Sell | 1,750 | $29.93 | $52,377.50 | -0.3% | -8.4% | -24.6% | |
| Apr 1, 2021 | Welgus Howard G.61 | Director | Sale+OE | 2,200 | $29.49 | $64,880.20 | -0.5% | -8.2% | -31.6% | |
| Mar 22, 2021 | Chaudhuri Bhaskar78 | Director | Sell | 10,000 | $31.10 | $311,020.74 | -0.6% | -13.3% | -43.6% | |
| Mar 10, 2021 | Smither John W65 | Chief Financial Officer | Sale+OE | 1,750 | $32.90 | $57,575.00 | -1.3% | -13.2% | -45.4% |